Consolidated Statements of Cash Flows $ in Millions	12 Months Ended
	Jan. 02, 2021 USD ($)		Dec. 28, 2019 USD ($)		Dec. 29, 2018 USD ($)
Operating Activities:
Net earnings	$ 1,234.7	[1]	$ 958.0	[1]	$ 605.8	[1]
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization of property, plant and equipment	376.5	[2]	372.8		331.2
Amortization of intangibles	201.6	[2]	187.4		175.3
Inventory step-up amortization	29.0	[2]	7.4		9.6
Loss (gain) on sales of businesses	13.5	[2]	(17.0)	[1]	0.8	[1]
Loss on debt extinguishments	46.9	[1]	17.9	[1]	0.0	[1]
Stock-based compensation expense	109.1	[2]	88.8		76.5
Provision for credit losses	41.1	[2]	33.0		28.0
Share of net (earnings) losses of equity method investment	(9.1)	[2]	11.2	[1]	0.0	[1]
Deferred tax (benefit) expense	(241.7)	[2]	(17.9)		191.1
Other non-cash items	44.7	[2]	(13.8)		10.1
Changes in operating assets and liabilities:
Accounts receivable	(39.6)	[2]	137.8		(48.8)
Inventories	(401.5)	[2]	137.7		(401.6)
Accounts payable	310.4	[2]	(169.1)		211.0
Deferred revenue	(0.3)	[2]	8.5		1.5
Other current assets	(100.2)	[2]	(183.6)		(4.4)
Other long-term assets	(14.0)	[2]	(37.3)		28.9
Accrued expenses	381.7	[2]	123.6		70.1
Defined benefit liabilities	(40.2)	[2]	(47.6)		(44.7)
Other long-term liabilities	79.5	[2]	(92.1)		20.5
Net cash provided by operating activities	2,022.1	[2]	1,505.7		1,260.9
Investing Activities:
Capital and software expenditures	(348.1)	[2]	(424.7)		(492.1)
Sales of assets	19.9	[2]	100.1		45.2
Business acquisitions, net of cash acquired	(1,324.4)	[2]	(685.4)		(524.6)
Sales of businesses, net of cash sold	59.1	[2]	76.6		(3.0)
Purchases of investments	(18.7)	[2]	(260.6)		(21.7)
Net investment hedge settlements	41.0	[2]	8.0		25.7
Other	(5.9)	[2]	(22.6)		(18.6)
Net cash used in investing activities	(1,577.1)	[2]	(1,208.6)		(989.1)
Financing Activities:
Payments on long-term debt	(1,154.3)	[2]	(1,150.0)		(977.5)
Proceeds from debt issuances, net of fees	2,222.5	[2]	496.2		990.0
Net short-term (repayments) borrowings	(342.6)	[2]	(18.1)		433.2
Stock purchase contract fees	59.8	[2]	40.3		40.3
Purchases of common stock for treasury	(26.2)	[2]	(27.5)		(527.1)
Proceeds from issuance of 2019 Equity Units	0.0		735.0		0.0
Proceeds from issuance of remarketed preferred stock	750.0	[2]	0.0		0.0
Premium paid on equity options	0.0	[2]	(19.2)		(57.3)
Premium paid on debt extinguishment	(48.7)	[2]	0.0		0.0
Proceeds from issuances of common stock	147.0	[2]	146.0		38.5
Craftsman deferred purchase price	(250.0)	[2]	0.0		0.0
Termination of interest rate swaps	(20.5)	[2]	(1.0)		(22.7)
Cash dividends on common stock	(431.8)	[2]	(402.0)		(384.9)
Cash dividends on preferred stock	(18.8)	[2]	0.0		0.0
Other	(10.6)	[2]	(11.6)		(13.5)
Net cash provided by (used in) financing activities	615.9	[2]	(292.5)		(561.6)
Effect of exchange rate changes on cash and cash equivalents	22.8	[2]	(1.4)		(53.9)
Change in cash, cash equivalents and restricted cash	1,083.7	[2]	3.2		(343.7)
Cash, cash equivalents and restricted cash, beginning of year	314.6	[2]	311.4		655.1
Cash, cash equivalents and restricted cash, end of year	1,398.3	[2]	314.6	[2]	311.4
Supplemental Cash Flow Information [Abstract]
Cash and cash equivalents	1,381.0		297.7
Restricted cash included in Other current assets	17.3		16.9
Cash, cash equivalents and restricted cash	1,398.3	[2]	314.6	[2]	311.4
Craftsman
Financing Activities:
Craftsman contingent consideration	45.9	[2]	0.0		0.0
Consolidated Aerospace Manufacturing (CAM)
Financing Activities:
Craftsman contingent consideration	$ 94.4	[2]	$ 0.0		$ 0.0

[1] See Note A, Significant Accounting Policies - Restatement, for discussion regarding the impacts of the Restatement.

[2] See Note A, Significant Accounting Policies - Restatement, for discussion regarding the impacts of the Restatement.